Savara Inc. (SVRA) - Latest Market Data

Price & Market Data

Price: $5.64

Daily Change: -$0.0778 / 1.38%

Daily Range: $5.49 - $6.08

Market Cap: $1,125,177,216

Daily Volume: 1,022,535

Performance Metrics

1 Week: -5.15%

1 Month: -10.66%

3 Months: 32.61%

6 Months: 78.96%

1 Year: 105.6%

YTD: -8.29%

Company Details

Employees: 59

Sector: Health technology

Industry: Pharmaceuticals: major

Country:

Details

Savara Inc., a clinical stage biopharmaceutical company, focuses on rare respiratory diseases. The company's lead product candidate is molgramostim, an inhaled granulocyte-macrophage colony-stimulating factor, which is in Phase 3 development stage for the treatment of autoimmune pulmonary alveolar proteinosis. The company was founded in 2007 and is headquartered in Langhorne, Pennsylvania.

Selected stocks

Taoping Inc. (TAOP)

Tao Synergies Inc. (TAOX)

Northann Corp. (NCL)